The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 4, 2009, Pages 412.e1-412.e6

  Goetzinger, Katherine R ^a   Singla, Ashima ^a   Gerkowicz, Sabrina ^a   Dicke, Jeffrey M ^a   Gray, Diana L ^a   Odibo, Anthony O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

fetal growth; free hCG; large for gestational age; PAPP A; small for gestational age

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PROTEIN A;

ADULT; ANEUPLOIDY; AREA UNDER THE CURVE; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; NEGRO; PREDICTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SCREENING;

EID: 70349330480     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.07.016     Document Type: Article

References (19)

1. Ong C.Y.T., Liao A.W., Spencer K., Munim S., and Nicolaides K.H. First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107 (2000) 1265-1270
2. Dugoff L., Hobbins J.C., Malone F.D., et al. First trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (The FASTER Trial). Am J Obstet Gynecol 191 (2004) 1446-1451
3. Peterson S.E., and Simhan H.N. First-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growth. Am J Obstet Gynecol 198 (2008) e43-e45
4. Krantz D., Goetzl L., Simpson J.L., et al. Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191 (2004) 1452-1458
5. Canini S., Prefumo F., Pastorino D., et al. Association between birth weight and first-trimester free β-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril 89 (2008) 174-178
6. Spencer K., Cowans N.J., Avgidou K., Molina F., and Nicolaides K.H. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 31 (2008) 15-19
7. Smith G.C.S., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., and Connor J.M. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87 (2002) 1762-1767
8. Tul N., Pusenjak S., Osredkar J., Spencer K., and Novak-Antolic Z. Predicting complications of pregnancy with first-trimester maternal serum free-β hCG, PAPP-A and inhibin-A. Prenat Diagn 23 (2003) 990-996
9. Smith G.C., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., and Connor J.M. Early-pregnancy origins of low birth weight. Nature 417 (2002) 916
10. Alexander G.R., Himes J.H., Kaufman R.B., Mor J., and Kogan M. A United States national reference for fetal growth. Obstet Gynecol 87 (1996) 163-168
11. Hosmer D.W., and Lemeshow S. Model-building strategies and methods for logistic regression. Applied logistic regression. 2 ed. (2000), Wiley, New York 91-96
12. Lawrence J.B., Oxvig C., Overgaard M.T., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein A. Proc Natl Acad Sci U S A 96 (1999) 3149-3153
13. Clemmons D.R. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 140 (1998) 19-24
14. Fox H. Effect of hypoxia on trophoblast in organ culture: a morphologic and autoradiographic study. Am J Obstet Gynecol 107 (1970) 1058-1064
15. Gonen R., Perez R., David M., Merksamer R., and Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 80 (1992) 83-85
16. Ilagan J.G., Stamilio D.M., Ural S.H., Macones G.A., and Odibo A.O. Abnormal multiple marker screens are associated with adverse perinatal outcome in cases of intrauterine growth restriction. Am J Obstet Gynecol 191 (2004) 1465-1469
17. Dicke J.M., Blanco V.M., Yan Y., and Coplen D.E. The type and frequency of fetal renal disorders and management of renal pelvis dilatation. J Ultrasound Med 25 (2006) 973-977
18. Dicke J.M., and Crane J.P. Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management. Obstet Gynecol 80 (1992) 778-782
19. Goetzinger K.R., Stamilio D.M., Dicke J.M., Macones G.A., and Odibo A.O. Evaluating the incidence and likelihood ratios for chromosomal abnormalities in fetuses with common central nervous system malformations. Am J Obstet Gynecol 199 (2008) 285.e1-285.e6